ID: ALA1254452

Max Phase: Preclinical

Molecular Formula: C20H41N5O7

Molecular Weight: 463.58

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H]([C@@H](C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O

Standard InChI:  InChI=1S/C20H41N5O7/c1-8(21)12-5-4-9(22)18(30-12)31-15-10(23)6-11(24)16(13(15)26)32-19-14(27)17(25-3)20(2,28)7-29-19/h8-19,25-28H,4-7,21-24H2,1-3H3/t8-,9-,10+,11-,12+,13+,14-,15-,16+,17-,18-,19-,20+/m1/s1

Standard InChI Key:  XUFIWSHGXVLULG-IDLVJFIQSA-N

Associated Targets(non-human)

Helicobacter pylori (3113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DNA (609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 463.58Molecular Weight (Monoisotopic): 463.3006AlogP: -3.59#Rotatable Bonds: 6
Polar Surface Area: 213.72Molecular Species: BASEHBA: 12HBD: 8
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 12#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.55CX Basic pKa: 10.01CX LogP: -3.57CX LogD: -11.56
Aromatic Rings: 0Heavy Atoms: 32QED Weighted: 0.19Np Likeness Score: 1.67

References

1. Joshi S, Fedoseyenko D, Mahanta N, Ducati RG, Feng M, Schramm VL, Begley TP..  (2019)  Antibacterial Strategy against H. pylori: Inhibition of the Radical SAM Enzyme MqnE in Menaquinone Biosynthesis.,  10  (3): [PMID:30891141] [10.1021/acsmedchemlett.8b00649]
2. Shahin IG,Abutaleb NS,Alhashimi M,Kassab AE,Mohamed KO,Taher AT,Seleem MN,Mayhoub AS.  (2020)  Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.,  202  [PMID:32707373] [10.1016/j.ejmech.2020.112497]
3. Guchhait S, Khononov A, Pieńko T, Belakhov V, Baasov T..  (2023)  Balancing Nonsense Mutation Readthrough and Toxicity of Designer Aminoglycosides for Treatment of Genetic Diseases.,  14  (6): [PMID:37312846] [10.1021/acsmedchemlett.3c00089]

Source